How big is Jenburkt Pharma?

Jul 24 2025 05:36 PM IST
share
Share Via
As of 24th July, Jenburkt Pharmaceuticals Ltd. has a market capitalization of 581.00 Cr, with net sales of 151.70 Cr and a net profit of 32.07 Cr reported in the latest four quarters. The balance sheet for March 2025 shows shareholder's funds of 171.78 Cr and total assets of 194.72 Cr.
As of 24th July, Jenburkt Pharmaceuticals Ltd. has a market capitalization of 581.00 Cr, categorizing it as a Micro Cap company.

In the latest four quarters, Jenburkt Pharmaceuticals reported net sales of 151.70 Cr and a net profit of 32.07 Cr.

The latest annual period for the balance sheet is March 2025, showing shareholder's funds of 171.78 Cr and total assets of 194.72 Cr.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News